| P2093 | author name string | Seyed E Hasnain | |
| | K J R Murthy | |
| | Vijaya Lakshmi Valluri | |
| | B Anuradha | |
| | V Hari Sai Priya | |
| | Suman Latha Gaddam | |
| P2860 | cites work | Antigen responsiveness during tuberculosis: regulatory interactions of T cell subpopulations and adherent cells | Q68996847 |
| | Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection | Q69004602 |
| | Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis | Q70375526 |
| | Dysregulated production of interferon-gamma, interleukin-4 and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis | Q73396193 |
| | Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra | Q77524567 |
| | Tuberculin specific T cell responses in BCG vaccinated children | Q81370321 |
| | Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project | Q28145755 |
| | Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment | Q33265416 |
| | Human immune response to Mycobacterium tuberculosis antigens | Q33383180 |
| | Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis | Q33748106 |
| | Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis | Q34007624 |
| | Interleukin 12 at the site of disease in tuberculosis | Q34140928 |
| | Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans | Q34361636 |
| | Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis | Q35403703 |
| | Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis | Q35503716 |
| | The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis | Q35655414 |
| | Immunology of tuberculosis | Q35936173 |
| | In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta | Q36107522 |
| | Alternatives to the tuberculin skin test: interferon-gamma assays in the diagnosis of mycobacterium tuberculosis infection | Q36229411 |
| | Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis | Q36960119 |
| | Biomarkers for TB treatment response: challenges and future strategies | Q37224923 |
| | The Mycobacterium bovis 32-kilodalton protein antigen induces human cytotoxic T-cell responses | Q39859304 |
| | Interferon-gamma Low producer genotype +874 overrepresented in Bacillus Calmette-Guerin nonresponding children | Q40108057 |
| | AIDS, tuberculosis, and the health care worker | Q40520651 |
| | Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes | Q40651348 |
| | Lymphokine production by human T cells in disease states | Q40661109 |
| | Age-related waning of in vitro Interferon-gamma levels against r32kDaBCG in BCG vaccinated children | Q42123473 |
| | Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease | Q43876739 |
| | Pulmonary tuberculosis: evaluation of interferon-gamma levels as an immunological healing marker based on the response to the Bacillus Calmette-Guerin. | Q44992835 |
| | Quantitative and qualitative studies on the major extracellular antigen of Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG. | Q53759011 |
| | Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens | Q56828019 |
| | Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis | Q64132302 |
| | Characterization of a factor(s) which synergizes with recombinant interleukin 2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitro | Q68124763 |
| P433 | issue | 1 | |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| | Mycobacterium bovis | Q133447 |
| P304 | page(s) | 111-115 | |
| P577 | publication date | 2008-11-05 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis | |
| P478 | volume | 16 | |